Test selection and interpretation of test results
It is recommended to start with the detection of spike protein, if possible by immunohistochemical analyses of tissue samples (biopsies), alternatively or additionally by ELISA of blood samples. As the detection of nucleic acids (modRNA and DNA) is significantly more time-consuming and cost-intensive, it should generally only be considered after positive detection of spike protein.
Although it is possible to analyse blood samples alone, the results of biopsies are generally more informative and specific. If the symptoms of the disease can be assigned to a specific organ, a biopsy should always be sought if possible. This will not be possible in many cases, but should be considered in advance, e.g. if an operation is imminent.
The results of the laboratory tests will be communicated to you in writing. It should be noted that these should ALWAYS be evaluated in conjunction with the individual medical history, clinical findings and the results of other diagnostic tests. Positive detection of “vaccine” specific nucleic acids or spike protein may support the diagnosis of vaccine injury, especially if this detection involves a diseased organ. However, a negative result does not necessarily rule out vaccine damage, especially if the vaccination was given some time ago.
Sample material requirements
At least 5 millilitres of EDTA whole blood must be submitted for blood tests. Tubes WITHOUT separator/gel (clot activator) must be used. At least 8 millilitres of fluid are required for cerebrospinal fluid examinations. Please send the samples by post or courier on the day of collection and avoid sending them over the weekend or on public holidays.
Biopsy or autopsy materials can be sent in a fixed or unfixed state. Tissue samples that have already been embedded in paraffin blocks for other analyses can also be requested by the relevant laboratories (e.g. pathology institutes) and sent to Inmodia GmbH. For samples that have not yet been fixed, it is important to ensure rapid transport and cooling of the samples.
You will receive the detailed information sheet after contacting our registration office. There you will also find out the shipping address.
Background knowledge on the quantitative determination of spike proteins in blood or cerebrospinal fluid
After uptake of the lipid nanoparticles (Pfizer and Moderna) or vector vaccines (Janssen, Astra Zeneca), the body’s cells produce spike proteins. These proteins can be cleaved off from the cell membrane and released into the plasma as free spike protein or into the blood via exosomes. At the same time, the immune cells can also take up the vaccines and produce spike proteins. Our highly sensitive ELISA (up to 1000 times more sensitive than all other assays on the market) detects and quantifies the amount of free spike proteins in the plasma, exosomes and immune cells (PBMC). Only the Wuhan variant, which was also used in the vaccines, is detected. Spike proteins that originate from an infection after January 2021 are not detected and measured. In this respect, this ELISA indirectly distinguishes between spike proteins from the vaccination or from an infection.
Background knowledge on the determination of plasmid DNA fragments and vaccine mRNA
The vaccine mRNA (Pfizer and Moderna) is transported into body cells via the lipid nanoparticles. These can be released again by the cells via exosomes. At the same time, the lipid nanoparticles are also taken up by immune cells. In this test, the exosomes and immune cells (PBMC) are examined for vaccine mRNA using a blood or cerebrospinal fluid sample.
Plasmid DNA was used as a template to produce the vaccine mRNA. Remnants of the plasmid DNA are still present in the lipid nanoparticles and thus enter the body’s cells. The DNA from the cells can return to the blood via the exosomes and continue to circulate there. At the same time, the lipid nanoparticles are also taken up by immune cells. In this test, the exosomes and immune cells (PBMC) are examined for plasmid DNA fragments using a blood or cerebrospinal fluid sample.
Price list (as of January 2025)
| Examinations on tissues and biopsies | Price (net) |
|---|---|
| Detection of spike proteins (vaccination/virus) and nucleocapsid proteins (virus) (IHC staining) | 350.00 € (one tissue), 540 – 800 € (2 – 5 tissues), 900 – 1250 € (6 – 10 tissues), upon request (complete collection after death) |
| Detection of vaccine-mRNA (differentiation between vaccination and virus possible) (FISH-staining) | 950.00 € |
| Detection of vaccine-mRNA in unfixed tissues and biopsies (differentiation between vaccination and virus possible) (PCR) | 190.00 € |
| Detection of plasmid DNA fragments from unfixed tissues and biopsies (PCR) | 200.00 € |
| Detection of plasmid DNA fragments from fixed tissues and biopsies (PCR) | 345.00 € |
| Quantitative analysis of spike proteins in unfixed tissues and biopsies | 400.00 € |
| Quantitative analysis of spike proteins in fixed tissues and biopsies | 510.00 € |
| Blood- and Liquorexaminations | Price (net) |
| Detection of vaccine-mRNA in blood or Liquor (2-Combo – immune cells and exosomes) | 245.00 € |
| Detection of plasmid DNA fragments in blood or liquor (Pfizer/Moderna)(2-Combo – immune cells and exosomes) | 245.00 € |
| Quantitative analysis of spike proteins in various blood components (3-Combo – plasma, exosomes, immune cells) | 510.00 € |
| Quantitative analysis of spike proteins in various blood components (2-Combo – plasma, immune cells) | 450.00 € |
| Quantitative analysis of spike proteins in various liquor components (3-Combo – plasma, exosomes, immune cells) | 510.00 € |
| Quantitative analysis of spike proteins in various liquor components (2-Combo – plasma, immune cells) | 450.00 € |
| Detection of spike proteins (vaccination/virus) and nucleocapsid proteins in blood immune cells (IHC staining) | 450.00 € |
| Detection of vaccine-mRNA in blood immune cells (differentiation between vaccination and virus possible) (FISH staining) | 450.00 € |
| other services | Price (net) |
| Mass spectroscopy – spike protein sequencing (vaccination vs infection) | only upon request and under certain conditions |
| Research project – genome sequencing and screening for plasmid DNA integrations into the cell genome | only upon request and under certain conditions |